Literature DB >> 23395810

Utility of an adverse drug event trigger tool in Veterans Affairs nursing facilities.

Zachary A Marcum1, Kelly L Arbogast, Michael C Behrens, Michael W Logsdon, Susan Dove Francis, Sean M Jeffery, Sherrie L Aspinall, Joseph T Hanlon, Steven M Handler.   

Abstract

OBJECTIVE: To determine the utility (i.e., positive predictive value [PPV] and time requirement) of an adverse drug event (ADE) trigger tool in Veterans Affairs (VA) nursing facilities and to describe the most common types of potential ADEs detected with the trigger tool.
DESIGN: Retrospective chart review. SETTING/PATIENTS: Veterans residing in three VA nursing facilities between September 29, 2010, and October 29, 2010. MEASUREMENT: We used the Institute for Healthcare Improvement-endorsed nursing facility ADE trigger tool, modified to enhance its clinical relevance to detect potential ADEs. Electronic medical records were screened to identify residents with one or more abnormal laboratory values specified in the trigger tool. MAIN OUTCOME MEASURES: A potential ADE was defined as the concurrent administration of medication that could cause the abnormal laboratory value. An overall PPV, or proportion of residents with an abnormal laboratory value who had a potential ADE, and average time required to complete each trigger tool assessment, were calculated.
RESULTS: Among 321 veterans, 50.5% (n = 162) had at least one abnormal laboratory value contained in the trigger tool. Ninety-nine potential ADEs involving 146 medications were detected in 65 veterans. The overall PPV of the ADE trigger tool was 40.1% (65/162), and the average time to complete resident assessments was 8.8 (standard deviation ± 5.7) minutes. The most common potential ADEs were acute kidney injury (n = 30 residents), hypokalemia (n = 18), hypoglycemia (n = 13), and hyperkalemia (n = 10).
CONCLUSIONS: The modified nursing facility trigger tool was shown to be an effective and efficient method for detecting potential ADEs.

Entities:  

Mesh:

Year:  2013        PMID: 23395810      PMCID: PMC3677952          DOI: 10.4140/TCP.n.2013.99

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  18 in total

1.  Methodology and rationale for the measurement of harm with trigger tools.

Authors:  R K Resar; J D Rozich; D Classen
Journal:  Qual Saf Health Care       Date:  2003-12

Review 2.  Epidemiology of medication-related adverse events in nursing homes.

Authors:  Steven M Handler; Rollin M Wright; Christine M Ruby; Joseph T Hanlon
Journal:  Am J Geriatr Pharmacother       Date:  2006-09

3.  Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care.

Authors:  R Singh; E A McLean-Plunckett; R Kee; A Wisniewski; R Cadzow; S Okazaki; C Fox; G Singh
Journal:  Qual Saf Health Care       Date:  2009-06

4.  Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting.

Authors:  Jerry H Gurwitz; Terry S Field; Paula Rochon; James Judge; Leslie R Harrold; Chaim M Bell; Monica Lee; Kathleen White; Jane LaPrino; Janet Erramuspe-Mainard; Martin DeFlorio; Linda Gavendo; Joann L Baril; George Reed; David W Bates
Journal:  J Am Geriatr Soc       Date:  2008-12       Impact factor: 5.562

5.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

6.  Predictive value of alert triggers for identification of developing adverse drug events.

Authors:  Carlton Moore; Jiang Li; Chang-Chiao Hung; John Downs; Jonathan R Nebeker
Journal:  J Patient Saf       Date:  2009-12       Impact factor: 2.844

7.  Detecting Adverse Drug Events Using a Nursing Home Specific Trigger Tool.

Authors:  Steven M Handler; Joseph T Hanlon
Journal:  Ann Longterm Care       Date:  2010-05

8.  Consensus guidelines for oral dosing of primarily renally cleared medications in older adults.

Authors:  Joseph T Hanlon; Sherrie L Aspinall; Todd P Semla; Steven D Weisbord; Linda F Fried; C Bernie Good; Michael J Fine; Roslyn A Stone; Mary Jo V Pugh; Michelle I Rossi; Steven M Handler
Journal:  J Am Geriatr Soc       Date:  2008-12-10       Impact factor: 5.562

9.  Adverse events related to drugs and drug withdrawal in nursing home residents.

Authors:  M B Gerety; J E Cornell; D T Plichta; M Eimer
Journal:  J Am Geriatr Soc       Date:  1993-12       Impact factor: 5.562

Review 10.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

View more
  15 in total

1.  Exposure to anticholinergic and sedative medicines as indicators of high-risk prescriptions in the elderly.

Authors:  Elodie Jean-Bart; Claire Moutet; Virginie Dauphinot; Pierre Krolak-Salmon; Christelle Mouchoux
Journal:  Int J Clin Pharm       Date:  2017-10-31

2.  Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method.

Authors:  Qiaozhi Hu; Zhou Qin; Mei Zhan; Bin Wu; Zhaoyan Chen; Ting Xu
Journal:  Int J Clin Pharm       Date:  2019-06-28

3.  Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.

Authors:  Daniel Sevilla-Sanchez; Núria Molist-Brunet; Jordi Amblàs-Novellas; Pere Roura-Poch; Joan Espaulella-Panicot; Carles Codina-Jané
Journal:  Eur J Clin Pharmacol       Date:  2016-10-04       Impact factor: 2.953

4.  Physician Perceptions of Consultant Pharmacist Services Associated with an Intervention for Adverse Drug Events in the Nursing Facility.

Authors:  Sandra L Kane-Gill; Joseph T Hanlon; Michael J Fine; Subashan Perera; Colleen M Culley; Stephanie A Studenski; Dave A Nace; Richard D Boyce; Nicholas G Castle; Steven M Handler
Journal:  Consult Pharm       Date:  2016-12-01

5.  Adverse drug events in Chinese pediatric inpatients and associated risk factors: a retrospective review using the Global Trigger Tool.

Authors:  Huan-Huan Ji; Lin Song; Jian-Wen Xiao; Yu-Xia Guo; Ping Wei; Ting-Ting Tang; Xiao-Jiang Tian; Xue-Wen Tang; Yun-Tao Jia
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379

6.  Determining the incidence of drug-associated acute kidney injury in nursing home residents.

Authors:  Steven M Handler; Pui Wen Cheung; Colleen M Culley; Subashan Perera; Sandra L Kane-Gill; John A Kellum; Zachary A Marcum
Journal:  J Am Med Dir Assoc       Date:  2014-05-10       Impact factor: 4.669

7.  Electronic Trigger-Based Intervention to Reduce Delays in Diagnostic Evaluation for Cancer: A Cluster Randomized Controlled Trial.

Authors:  Daniel R Murphy; Louis Wu; Eric J Thomas; Samuel N Forjuoh; Ashley N D Meyer; Hardeep Singh
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

8.  Development of a standardized chart review method to identify drug-related hospital admissions in older people.

Authors:  Stefanie Thevelin; Anne Spinewine; Jean-Baptiste Beuscart; Benoit Boland; Sophie Marien; Fanny Vaillant; Ingeborg Wilting; Ariel Vondeling; Carmen Floriani; Claudio Schneider; Jacques Donzé; Nicolas Rodondi; Shane Cullinan; Denis O'Mahony; Olivia Dalleur
Journal:  Br J Clin Pharmacol       Date:  2018-08-17       Impact factor: 4.335

9.  Using a Clinical Surveillance System to Detect Drug-Associated Hypoglycemia in Nursing Home Residents.

Authors:  Colleen M Culley; Subashan Perera; Zachary A Marcum; Sandra L Kane-Gill; Steven M Handler
Journal:  J Am Geriatr Soc       Date:  2015-10-12       Impact factor: 5.562

10.  Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity.

Authors:  Maria Jose Otero; María Dolores Toscano Guzmán; Mercedes Galván-Banqueri; Jesus Martinez-Sotelo; María Dolores Santos-Rubio
Journal:  Eur J Hosp Pharm       Date:  2020-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.